Cite
HARVARD Citation
Bi, W. et al. (2022). Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro-oncology. 24 (1), pp. 101-113. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bi, W. et al. (2022). Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro-oncology. 24 (1), pp. 101-113. [Online].